Sentinel Diagnostics

Executive Summary

Sentinel Diagnostics is an Italian private company founded in 2008, dedicated to the research and development of innovative in-vitro diagnostic (IVD) medical devices. The company's mission centers on enhancing clinical diagnostic reliability and serving as a trusted reference in laboratory medicine. Based in Milan, Sentinel Diagnostics focuses on developing advanced diagnostic tools aimed at improving accuracy and efficiency in clinical laboratories. While specific financial and pipeline details are limited, the company operates in the growing IVD market, driven by increasing demand for precise diagnostics and personalized medicine. Sentinel Diagnostics likely leverages expertise in areas such as immunoassays, molecular diagnostics, or clinical chemistry, though exact product lines are not disclosed. The company's commitment to innovation positions it to capture opportunities in the European diagnostic landscape, where regulatory standards and technological advancements are key drivers.

Upcoming Catalysts (preview)

• Q3 2026CE Marking for New Diagnostic Assay70% success
• Q1 2027Strategic Partnership with European Laboratory Network50% success
• Q4 2026Series B Funding Round for Commercial Expansion60% success